135 related articles for article (PubMed ID: 17576338)
1. Differentiating spitzoid melanomas from Spitz nevi through CD99 expression.
King MS; Porchia SJ; Hiatt KM
J Cutan Pathol; 2007 Jul; 34(7):576-80. PubMed ID: 17576338
[TBL] [Abstract][Full Text] [Related]
2. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-2 as a useful marker in the differentiation between Spitzoid malignant melanoma and Spitz nevus.
Wititsuwannakul J; Mason AR; Klump VR; Lazova R
J Am Acad Dermatol; 2013 Jan; 68(1):129-37. PubMed ID: 22954749
[TBL] [Abstract][Full Text] [Related]
4. Imaging mass spectrometry--a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas.
Lazova R; Seeley EH; Keenan M; Gueorguieva R; Caprioli RM
Am J Dermatopathol; 2012 Feb; 34(1):82-90. PubMed ID: 22197864
[TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
[TBL] [Abstract][Full Text] [Related]
6. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the expression of vimentin and actin in spitz nevi and spitzoid malignant melanomas.
Alomari AK; Klump V; Neumeister V; Ariyan S; Narayan D; Lazova R
Am J Dermatopathol; 2015 Jan; 37(1):46-51. PubMed ID: 25548991
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
van Dijk MC; Bernsen MR; Ruiter DJ
Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
[TBL] [Abstract][Full Text] [Related]
9. PRAME immunohistochemistry of spitzoid neoplasms.
Koh SS; Lau SK; Scapa JV; Cassarino DS
J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
[TBL] [Abstract][Full Text] [Related]
10. Intradermal spitz nevi: a rare subtype of spitz nevi analyzed in a clinicopathologic study of 74 cases.
Plaza JA; De Stefano D; Suster S; Prieto VG; Kacerovska D; Michal M; Sangueza M; Kazakov DV
Am J Dermatopathol; 2014 Apr; 36(4):283-94; quiz 295-7. PubMed ID: 24736667
[TBL] [Abstract][Full Text] [Related]
11. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
Garola R; Singh V
Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
[TBL] [Abstract][Full Text] [Related]
12. S100A6 protein expression is different in Spitz nevi and melanomas.
Ribé A; McNutt NS
Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
[TBL] [Abstract][Full Text] [Related]
13. A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas.
Bergman R; Azzam H; Sprecher E; Manov L; Munichor M; Friedman-Birnbaum R; Ben-Itzhak O
J Am Acad Dermatol; 2000 Mar; 42(3):496-500. PubMed ID: 10688724
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity of CD99 in invasive malignant melanoma.
Wilkerson AE; Glasgow MA; Hiatt KM
J Cutan Pathol; 2006 Oct; 33(10):663-6. PubMed ID: 17026517
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
[TBL] [Abstract][Full Text] [Related]
16. Ciliation Index Is a Useful Diagnostic Tool in Challenging Spitzoid Melanocytic Neoplasms.
Lang UE; Torres R; Cheung C; Vladar EK; McCalmont TH; Kim J; Judson-Torres RL
J Invest Dermatol; 2020 Jul; 140(7):1401-1409.e2. PubMed ID: 31978411
[TBL] [Abstract][Full Text] [Related]
17. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
[TBL] [Abstract][Full Text] [Related]
18. Nestin Expression in Spitzoid Lesions: An Immunohistochemical Characterization With Clinical and Dermoscopic Correlations.
Guanziroli E; Del Gobbo A; Coggi A; Venegoni L; Fanoni D; Ercoli G; Boggio F; Veraldi S; Cavicchini S; Berti E; Ferrero S; Gianotti R
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):430-435. PubMed ID: 30212379
[TBL] [Abstract][Full Text] [Related]
19. Problematic lesions in children.
Moscarella E; Piccolo V; Argenziano G; Lallas A; Longo C; Castagnetti F; Pizzigoni S; Zalaudek I
Dermatol Clin; 2013 Oct; 31(4):535-47, vii. PubMed ID: 24075543
[TBL] [Abstract][Full Text] [Related]
20. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
